BridgeMD
Tests treatment safety and results for Chronic Insomnia
Official title Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR)
ClinicalTrials.gov ID: NCT06898099
What this study is testing
- What it's testing
- In France, the treatment of chronic insomnia relies mainly on hypnotic drugs in routine care, despite the high level of iatrogenicity. Cognitive-behavioral therapy (CBT) is recommended by the HAS as a non-pharmaceutical first-line therapy for chronic insomnia.
- Time commitment: about 6 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient aged 18 or over,
- Patient suffering from chronic insomnia according to the DSM-5 definition, whether or not treated with psychotropic drugs: \ At least one of the...
- Patient willing to undergo hypnotherapy for 4 sessions of 30 min over 6 weeks,
- Patient whose treating physician is the investigator,
- Patient able to give free, informed, written consent,
You likely can't join if
- Patients receiving or having received one or more hypnotherapy sessions (for any reason) in the last 5 years prior to inclusion,
- Patient participating in another study involving the treatment of insomnia or another pathology having an impact on sleep disorders,
- Patient unable to complete a self-administered questionnaire,
- Patients with poor or no understanding of the French language,
- Patients unable to attend hypnotherapy consultations,
- Deaf or hard-of-hearing patients without hearing aids,
See the full eligibility criteria
- Patient aged 18 or over,
- Patient suffering from chronic insomnia according to the DSM-5 definition, whether or not treated with psychotropic drugs: \ At least one of the following sleep disorders: difficulty in falling asleep, difficulty in...
- Patient willing to undergo hypnotherapy for 4 sessions of 30 min over 6 weeks,
- Patient whose treating physician is the investigator,
- Patient able to give free, informed, written consent,
- Patient affiliated to the French social security system.
- Patients receiving or having received one or more hypnotherapy sessions (for any reason) in the last 5 years prior to inclusion,
- Patient participating in another study involving the treatment of insomnia or another pathology having an impact on sleep disorders,
- Patient unable to complete a self-administered questionnaire,
- Patients with poor or no understanding of the French language,
- Patients unable to attend hypnotherapy consultations,
- Deaf or hard-of-hearing patients without hearing aids,
- Patient under legal protection (safeguard of justice, curatorship, guardianship) or deprived of liberty,
- Women declaring themselves pregnant or breastfeeding.
The study team makes the final eligibility decision.
Where it's taking place
- Bain-de-Bretagne, France
- Bouaye, France
- Breteil, France
- Cesson-Sévigné, France
- Combourg, France
- Contres, France
- Corps-Nuds, France
- Crac'h, France
- Dol-de-Bretagne, France
- Guer, France
- Iffendic, France
- Joué Les Tours, France
- Jugon-les-Lacs, France
- La Chapelle-des-Fougeretz, France
- La Chapelle-Saint-Ursin, France
- Nantes, France
- Pleudihen-sur-Rance, France
- Ploërmel, France
- Pont-Saint-Martin, France
- Questembert, France
+ 11 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bain-de-Bretagne, France; Bouaye, France; Breteil, France; Cesson-Sévigné, France; Combourg, France; Contres, France and 25 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.